These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25375338)

  • 21. In vitro methods for screening transdermal formulations.
    Tsai PC; Lee S; Michniak-Kohn B
    Ther Deliv; 2015; 6(9):1043-52. PubMed ID: 26419344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products.
    Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
    Skin Therapy Lett; 2012 Jun; 17(6):5-7. PubMed ID: 22735504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal patches: Design and current approaches to painless drug delivery.
    Al Hanbali OA; Khan HMS; Sarfraz M; Arafat M; Ijaz S; Hameed A
    Acta Pharm; 2019 Jun; 69(2):197-215. PubMed ID: 31259729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid-State Stability Issues of Drugs in Transdermal Patch Formulations.
    Sharma PK; Panda A; Pradhan A; Zhang J; Thakkar R; Whang CH; Repka MA; Murthy SN
    AAPS PharmSciTech; 2018 Jan; 19(1):27-35. PubMed ID: 28895101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhesive properties: a critical issue in transdermal patch development.
    Cilurzo F; Gennari CG; Minghetti P
    Expert Opin Drug Deliv; 2012 Jan; 9(1):33-45. PubMed ID: 22171789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin electroporation for transdermal and topical delivery.
    Denet AR; Vanbever R; Préat V
    Adv Drug Deliv Rev; 2004 Mar; 56(5):659-74. PubMed ID: 15019751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Predictive Model for the Stabilizer Concentration Estimation in Microreservoir Transdermal Drug Delivery Systems Using Lipophilic Pressure-Sensitive Adhesives as Matrix/Carrier.
    Chenevas-Paule C; Wolff HM; Ashton M; Schubert M; Dodou K
    J Pharm Sci; 2017 May; 106(5):1371-1383. PubMed ID: 28163134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal drug delivery.
    Guy RH
    Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vesicular carriers for dermal drug delivery.
    Sinico C; Fadda AM
    Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applicability, Commercial Utility and Recent Patents on Starch and Starch Derivative as Pharmaceutical Drug Delivery Carrier.
    Pandey S; Malviya R; Sharma PK
    Recent Pat Drug Deliv Formul; 2015; 9(3):249-56. PubMed ID: 26205680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coming of age of lipid-based drug delivery systems.
    Davis SS
    Adv Drug Deliv Rev; 2004 May; 56(9):1241-2. PubMed ID: 15109766
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemistry, manufacturing and controls in passive transdermal drug delivery systems.
    Goswami T; Audett J
    Ther Deliv; 2015; 6(9):1071-9. PubMed ID: 26389777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal delivery: product and patent update.
    Gupta H; Babu RJ
    Recent Pat Drug Deliv Formul; 2013 Dec; 7(3):184-205. PubMed ID: 24025130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches.
    Karve T; Dandekar A; Agrahari V; Melissa Peet M; Banga AK; Doncel GF
    Adv Drug Deliv Rev; 2024 Jul; 210():115326. PubMed ID: 38692457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug delivery global summit--evaluating emerging technologies.
    Mustata G; Dinh SM
    Expert Opin Drug Deliv; 2005 Jan; 2(1):185-7. PubMed ID: 16296744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contact lenses as drug reservoirs & delivery systems: the successes & challenges.
    ElShaer A; Ghatora B; Mustafa S; Alany RG
    Ther Deliv; 2014 Oct; 5(10):1085-100. PubMed ID: 25418268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymer therapeutics--polymers as drugs, drug and protein conjugates and gene delivery systems: past, present and future opportunities.
    Duncan R; Ringsdorf H; Satchi-Fainaro R
    J Drug Target; 2006 Jul; 14(6):337-41. PubMed ID: 17092834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.